{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:38:13Z","timestamp":1790674693194,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,11,7]],"date-time":"2013-11-07T00:00:00Z","timestamp":1383782400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s12035-013-8556-x","type":"journal-article","created":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T03:38:01Z","timestamp":1383709081000},"page":"784-795","source":"Crossref","is-referenced-by-count":36,"title":["Prostaglandin E2 EP1 Receptor Antagonist Improves Motor Deficits and Rescues Memory Decline in R6\/1 Mouse Model of Huntington's Disease"],"prefix":"10.1007","volume":"49","author":[{"given":"Marta","family":"Anglada-Huguet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Xifr\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonsa","family":"Zamora-Moratalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo D","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Alberch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,7]]},"reference":[{"key":"8556_CR1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"HDCRG","year":"1993","unstructured":"HDCRG (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"8556_CR2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57:369\u2013384","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Pt 7","key":"8556_CR3","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/brain\/121.7.1329","volume":"121","author":"AD Lawrence","year":"1998","unstructured":"Lawrence AD, Hodges JR, Rosser AE, Kershaw A, ffrench-Constant C, Rubinsztein DC, Robbins TW, Sahakian BJ (1998) Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain 121(Pt 7):1329\u20131341","journal-title":"Brain"},{"key":"8556_CR4","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00415-004-0461-9","volume":"251","author":"J Lemiere","year":"2004","unstructured":"Lemiere J, Decruyenaere M, Evers-Kiebooms G, Vandenbussche E, Dom R (2004) Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation\u2014a longitudinal follow-up study. J Neurol 251:935\u2013942","journal-title":"J Neurol"},{"key":"8556_CR5","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/hmg\/ddr552","volume":"21","author":"A Giralt","year":"2012","unstructured":"Giralt A, Puigdellivol M, Carreton O, Paoletti P, Valero J, Parra-Damas A, Saura CA, Alberch J, Gines S (2012) Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity. Hum Mol Genet 21:1203\u20131216","journal-title":"Hum Mol Genet"},{"key":"8556_CR6","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1523\/JNEUROSCI.20-13-05115.2000","volume":"20","author":"KP Murphy","year":"2000","unstructured":"Murphy KP, Carter RJ, Lione LA, Mangiarini L, Mahal A, Bates GP, Dunnett SB, Morton AJ (2000) Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation. J Neurosci 20:5115\u20135123","journal-title":"J Neurosci"},{"key":"8556_CR7","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","volume":"85","author":"A Reiner","year":"1988","unstructured":"Reiner A, Albin RL, Anderson KD, D'Amato CJ, Penney JB, Young AB (1988) Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A 85:5733\u20135737","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8556_CR8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"8556_CR9","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/01.WNL.0000065888.88988.6E","volume":"60","author":"HD Rosas","year":"2003","unstructured":"Rosas HD, Koroshetz WJ, Chen YI, Skeuse C, Vangel M, Cudkowicz ME, Caplan K, Marek K, Seidman LJ, Makris N, Jenkins BG, Goldstein JM (2003) Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 60:1615\u20131620","journal-title":"Neurology"},{"key":"8556_CR10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/jnnp.56.5.487","volume":"56","author":"E Spargo","year":"1993","unstructured":"Spargo E, Everall IP, Lantos PL (1993) Neuronal loss in the hippocampus in Huntington's disease: a comparison with HIV infection. J Neurol Neurosurg Psychiatry 56:487\u2013491","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8556_CR11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbadis.2011.10.016","volume":"1822","author":"PH Reddy","year":"2012","unstructured":"Reddy PH, Shirendeb UP (2012) Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease. Biochim Biophys Acta 1822:101\u2013110","journal-title":"Biochim Biophys Acta"},{"key":"8556_CR12","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.molmed.2003.08.006","volume":"9","author":"JY Li","year":"2003","unstructured":"Li JY, Plomann M, Brundin P (2003) Huntington's disease: a synaptopathy? Trends Mol Med 9:414\u2013420","journal-title":"Trends Mol Med"},{"key":"8556_CR13","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/hmg\/ddl092","volume":"15","author":"AJ Milnerwood","year":"2006","unstructured":"Milnerwood AJ, Cummings DM, Dallerac GM, Brown JY, Vatsavayai SC, Hirst MC, Rezaie P, Murphy KP (2006) Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease. Hum Mol Genet 15:1690\u20131703","journal-title":"Hum Mol Genet"},{"key":"8556_CR14","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuroscience.2011.08.052","volume":"198","author":"LA Raymond","year":"2011","unstructured":"Raymond LA, Andre VM, Cepeda C, Gladding CM, Milnerwood AJ, Levine MS (2011) Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function. Neuroscience 198:252\u2013273","journal-title":"Neuroscience"},{"key":"8556_CR15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ (2011) Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10:83\u201398","journal-title":"Lancet Neurol"},{"key":"8556_CR16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/toxsci\/kfj022","volume":"89","author":"AS Ahmad","year":"2006","unstructured":"Ahmad AS, Saleem S, Ahmad M, Dore S (2006) Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage. Toxicol Sci 89:265\u2013270","journal-title":"Toxicol Sci"},{"key":"8556_CR17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.pharmthera.2005.04.011","volume":"112","author":"SJ Hewett","year":"2006","unstructured":"Hewett SJ, Bell SC, Hewett JA (2006) Contributions of cyclooxygenase-2 to neuroplasticity and neuropathology of the central nervous system. Pharmacol Ther 112:335\u2013357","journal-title":"Pharmacol Ther"},{"key":"8556_CR18","doi-asserted-by":"crossref","first-page":"11678","DOI":"10.1523\/JNEUROSCI.4665-09.2010","volume":"30","author":"H Koch","year":"2010","unstructured":"Koch H, Huh SE, Elsen FP, Carroll MS, Hodge RD, Bedogni F, Turner MS, Hevner RF, Ramirez JM (2010) Prostaglandin E2-induced synaptic plasticity in neocortical networks of organotypic slice cultures. J Neurosci 30:11678\u201311687","journal-title":"J Neurosci"},{"key":"8556_CR19","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/brain\/awn008","volume":"131","author":"LA Kotilinek","year":"2008","unstructured":"Kotilinek LA, Westerman MA, Wang Q, Panizzon K, Lim GP, Simonyi A, Lesne S, Falinska A, Younkin LH, Younkin SG, Rowan M, Cleary J, Wallis RA, Sun GY, Cole G, Frautschy S, Anwyl R, Ashe KH (2008) Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity. Brain 131:651\u2013664","journal-title":"Brain"},{"key":"8556_CR20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1471-4159.2008.05766.x","volume":"108","author":"H Yang","year":"2009","unstructured":"Yang H, Zhang J, Breyer RM, Chen C (2009) Altered hippocampal long-term synaptic plasticity in mice deficient in the PGE2 EP2 receptor. J Neurochem 108:295\u2013304","journal-title":"J Neurochem"},{"key":"8556_CR21","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1146\/annurev.pharmtox.41.1.661","volume":"41","author":"RM Breyer","year":"2001","unstructured":"Breyer RM, Bagdassarian CK, Myers SA, Breyer MD (2001) Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 41:661\u2013690","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"8556_CR22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.brainres.2005.10.068","volume":"1066","author":"AS Ahmad","year":"2005","unstructured":"Ahmad AS, Ahmad M, de Brum-Fernandes AJ, Dore S (2005) Prostaglandin EP4 receptor agonist protects against acute neurotoxicity. Brain Res 1066:71\u201377","journal-title":"Brain Res"},{"key":"8556_CR23","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/ana.20179","volume":"56","author":"M Bilak","year":"2004","unstructured":"Bilak M, Wu L, Wang Q, Haughey N, Conant K, St HC, Andreasson K (2004) PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis. Ann Neurol 56:240\u2013248","journal-title":"Ann Neurol"},{"key":"8556_CR24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1523\/JNEUROSCI.4485-03.2004","volume":"24","author":"L McCullough","year":"2004","unstructured":"McCullough L, Wu L, Haughey N, Liang X, Hand T, Wang Q, Breyer RM, Andreasson K (2004) Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. J Neurosci 24:257\u2013268","journal-title":"J Neurosci"},{"key":"8556_CR25","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1002\/jnr.21425","volume":"85","author":"E Carrasco","year":"2007","unstructured":"Carrasco E, Casper D, Werner P (2007) PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity. J Neurosci Res 85:3109\u20133117","journal-title":"J Neurosci Res"},{"key":"8556_CR26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nm1362","volume":"12","author":"T Kawano","year":"2006","unstructured":"Kawano T, Anrather J, Zhou P, Park L, Wang G, Frys KA, Kunz A, Cho S, Orio M, Iadecola C (2006) Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat Med 12:225\u2013229","journal-title":"Nat Med"},{"key":"8556_CR27","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.neurobiolaging.2011.09.017","volume":"33","author":"G Zhen","year":"2012","unstructured":"Zhen G, Kim YT, Li RC, Yocum J, Kapoor N, Langer J, Dobrowolski P, Maruyama T, Narumiya S, Dore S (2012) PGE2 EP1 receptor exacerbated neurotoxicity in a mouse model of cerebral ischemia and Alzheimer's disease. Neurobiol Aging 33:2215\u20132219","journal-title":"Neurobiol Aging"},{"key":"8556_CR28","doi-asserted-by":"crossref","first-page":"12900","DOI":"10.1523\/JNEUROSCI.3257-07.2007","volume":"27","author":"S Kitaoka","year":"2007","unstructured":"Kitaoka S, Furuyashiki T, Nishi A, Shuto T, Koyasu S, Matsuoka T, Miyasaka M, Greengard P, Narumiya S (2007) Prostaglandin E2 acts on EP1 receptor and amplifies both dopamine D1 and D2 receptor signaling in the striatum. J Neurosci 27:12900\u201312907","journal-title":"J Neurosci"},{"key":"8556_CR29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.prostaglandins.2009.04.003","volume":"91","author":"K Andreasson","year":"2010","unstructured":"Andreasson K (2010) Emerging roles of PGE2 receptors in models of neurological disease. Prostaglandins Other Lipid Mediat 91:104\u2013112","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"8556_CR30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493\u2013506","journal-title":"Cell"},{"key":"8556_CR31","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.neuroscience.2008.11.024","volume":"158","author":"A Giralt","year":"2009","unstructured":"Giralt A, Rodrigo T, Martin ED, Gonzalez JR, Mila M, Cena V, Dierssen M, Canals JM, Alberch J (2009) Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: involvement of phospholipaseCgamma activity and glutamate receptor expression. Neuroscience 158:1234\u20131250","journal-title":"Neuroscience"},{"key":"8556_CR32","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","volume":"24","author":"JM Canals","year":"2004","unstructured":"Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Martin-Ibanez R, Munoz MT, Mengod G, Ernfors P, Alberch J (2004) Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease. J Neurosci 24:7727\u20137739","journal-title":"J Neurosci"},{"key":"8556_CR33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1750-1326-6-71","volume":"6","author":"A Giralt","year":"2011","unstructured":"Giralt A, Carreton O, Lao-Peregrin C, Martin ED, Alberch J (2011) Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction. Mol Neurodegener 6:71","journal-title":"Mol Neurodegener"},{"key":"8556_CR34","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","volume":"22","author":"RJ Ferrante","year":"2002","unstructured":"Ferrante RJ, Andreassen OA, Dedeoglu A, Ferrante KL, Jenkins BG, Hersch SM, Beal MF (2002) Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease. J Neurosci 22:1592\u20131599","journal-title":"J Neurosci"},{"key":"8556_CR35","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1093\/hmg\/ddr351","volume":"20","author":"A Giralt","year":"2011","unstructured":"Giralt A, Saavedra A, Carreton O, Xifro X, Alberch J, Perez-Navarro E (2011) Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease. Hum Mol Genet 20:4232\u20134247","journal-title":"Hum Mol Genet"},{"key":"8556_CR36","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1471-4159.2012.07711.x","volume":"121","author":"M Anglada-Huguet","year":"2012","unstructured":"Anglada-Huguet M, Giralt A, Perez-Navarro E, Alberch J, Xifro X (2012) Activation of Elk-1 participates as a neuroprotective compensatory mechanism in models of Huntington's disease. J Neurochem 121:639\u2013648","journal-title":"J Neurochem"},{"key":"8556_CR37","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.nbd.2009.08.012","volume":"36","author":"X Xifro","year":"2009","unstructured":"Xifro X, Giralt A, Saavedra A, Garcia-Martinez JM, Diaz-Hernandez M, Lucas JJ, Alberch J, Perez-Navarro E (2009) Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: role in excitotoxicity. Neurobiol Dis 36:461\u2013469","journal-title":"Neurobiol Dis"},{"key":"8556_CR38","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/gt.2010.71","volume":"17","author":"A Giralt","year":"2010","unstructured":"Giralt A, Friedman HC, Caneda-Ferron B, Urban N, Moreno E, Rubio N, Blanco J, Peterson A, Canals JM, Alberch J (2010) BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington's disease. Gene Ther 17:1294\u20131308","journal-title":"Gene Ther"},{"key":"8556_CR39","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1460-9568.2005.03925.x","volume":"21","author":"ED Martin","year":"2005","unstructured":"Martin ED, Buno W (2005) Stabilizing effects of extracellular ATP on synaptic efficacy and plasticity in hippocampal pyramidal neurons. Eur J Neurosci 21:936\u2013944","journal-title":"Eur J Neurosci"},{"key":"8556_CR40","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pneurobio.2009.04.005","volume":"90","author":"R Schwarcz","year":"2010","unstructured":"Schwarcz R, Guidetti P, Sathyasaikumar KV, Muchowski PJ (2010) Of mice, rats and men: revisiting the quinolinic acid hypothesis of Huntington's disease. Prog Neurobiol 90:230\u2013245","journal-title":"Prog Neurobiol"},{"key":"8556_CR41","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.nbd.2007.11.006","volume":"29","author":"J Nithianantharajah","year":"2008","unstructured":"Nithianantharajah J, Barkus C, Murphy M, Hannan AJ (2008) Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice. Neurobiol Dis 29:490\u2013504","journal-title":"Neurobiol Dis"},{"key":"8556_CR42","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.nbd.2007.10.003","volume":"29","author":"JF Torres-Peraza","year":"2008","unstructured":"Torres-Peraza JF, Giralt A, Garcia-Martinez JM, Pedrosa E, Canals JM, Alberch J (2008) Disruption of striatal glutamatergic transmission induced by mutant huntingtin involves remodeling of both postsynaptic density and NMDA receptor signaling. Neurobiol Dis 29:409\u2013421","journal-title":"Neurobiol Dis"},{"key":"8556_CR43","doi-asserted-by":"crossref","first-page":"13153","DOI":"10.1074\/jbc.M809229200","volume":"284","author":"PO Bauer","year":"2009","unstructured":"Bauer PO, Wong HK, Oyama F, Goswami A, Okuno M, Kino Y, Miyazaki H, Nukina N (2009) Inhibition of Rho kinases enhances the degradation of mutant huntingtin. J Biol Chem 284:13153\u201313164","journal-title":"J Biol Chem"},{"key":"8556_CR44","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bbr.2011.12.045","volume":"229","author":"RM Cowin","year":"2012","unstructured":"Cowin RM, Roscic A, Bui N, Graham D, Paganetti P, Jankowsky JL, Weiss A, Paylor R (2012) Neuronal aggregates are associated with phenotypic onset in the R6\/2 Huntington's disease transgenic mouse. Behav Brain Res 229:308\u2013319","journal-title":"Behav Brain Res"},{"issue":"1","key":"8556_CR45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11481-012-9380-1","volume":"8","author":"X Li","year":"2012","unstructured":"Li X, Rose SE, Montine KS, Keene CD, Montine TJ (2012) Antagonism of neuronal prostaglandin E(2) receptor subtype 1 mitigates amyloid beta neurotoxicity in vitro. J Neuroimmune Pharmacol 8(1):87\u201393","journal-title":"J Neuroimmune Pharmacol"},{"key":"8556_CR46","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/27094","volume":"395","author":"MJ Berridge","year":"1998","unstructured":"Berridge MJ, Bootman MD, Lipp P (1998) Calcium\u2014a life and death signal. Nature 395:645\u2013648","journal-title":"Nature"},{"key":"8556_CR47","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/iub.91","volume":"60","author":"U Wojda","year":"2008","unstructured":"Wojda U, Salinska E, Kuznicki J (2008) Calcium ions in neuronal degeneration. IUBMB Life 60:575\u2013590","journal-title":"IUBMB Life"},{"key":"8556_CR48","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1046\/j.0953-816x.2001.01767.x","volume":"14","author":"O Hansson","year":"2001","unstructured":"Hansson O, Guatteo E, Mercuri NB, Bernardi G, Li XJ, Castilho RF, Brundin P (2001) Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene. Eur J Neurosci 14:1492\u20131504","journal-title":"Eur J Neurosci"},{"key":"8556_CR49","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","volume":"23","author":"JG Hodgson","year":"1999","unstructured":"Hodgson JG, Agopyan N, Gutekunst CA, Leavitt BR, LePiane F, Singaraja R, Smith DJ, Bissada N, McCutcheon K, Nasir J, Jamot L, Li XJ, Stevens ME, Rosemond E, Roder JC, Phillips AG, Rubin EM, Hersch SM, Hayden MR (1999) A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23:181\u2013192","journal-title":"Neuron"},{"key":"8556_CR50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11010-007-9523-5","volume":"305","author":"L Zhang","year":"2007","unstructured":"Zhang L, Jiang L, Sun Q, Peng T, Lou K, Liu N, Leng J (2007) Prostaglandin E2 enhances mitogen-activated protein kinase\/Erk pathway in human cholangiocarcinoma cells: involvement of EP1 receptor, calcium and EGF receptors signaling. Mol Cell Biochem 305:19\u201326","journal-title":"Mol Cell Biochem"},{"key":"8556_CR51","doi-asserted-by":"crossref","first-page":"10090","DOI":"10.1523\/JNEUROSCI.3237-08.2008","volume":"28","author":"P Paoletti","year":"2008","unstructured":"Paoletti P, Vila I, Rife M, Lizcano JM, Alberch J, Gines S (2008) Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration: the role of p25\/cyclin-dependent kinase 5. J Neurosci 28:10090\u201310101","journal-title":"J Neurosci"},{"key":"8556_CR52","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1523\/JNEUROSCI.1396-07.2007","volume":"27","author":"TS Tang","year":"2007","unstructured":"Tang TS, Chen X, Liu J, Bezprozvanny I (2007) Dopaminergic signaling and striatal neurodegeneration in Huntington's disease. J Neurosci 27:7899\u20137910","journal-title":"J Neurosci"},{"key":"8556_CR53","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.nbd.2003.08.024","volume":"14","author":"R Luthi-Carter","year":"2003","unstructured":"Luthi-Carter R, Apostol BL, Dunah AW, DeJohn MM, Farrell LA, Bates GP, Young AB, Standaert DG, Thompson LM, Cha JH (2003) Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation. Neurobiol Dis 14:624\u2013636","journal-title":"Neurobiol Dis"},{"key":"8556_CR54","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/brain\/awh058","volume":"127","author":"BR Jarabek","year":"2004","unstructured":"Jarabek BR, Yasuda RP, Wolfe BB (2004) Regulation of proteins affecting NMDA receptor-induced excitotoxicity in a Huntington's mouse model. Brain 127:505\u2013516","journal-title":"Brain"},{"key":"8556_CR55","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/hmg\/8.5.839","volume":"8","author":"MT Usdin","year":"1999","unstructured":"Usdin MT, Shelbourne PF, Myers RM, Madison DV (1999) Impaired synaptic plasticity in mice carrying the Huntington's disease mutation. Hum Mol Genet 8:839\u2013846","journal-title":"Hum Mol Genet"},{"key":"8556_CR56","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainresbull.2011.10.002","volume":"88","author":"SP Brooks","year":"2012","unstructured":"Brooks SP, Jones L, Dunnett SB (2012) Comparative analysis of pathology and behavioural phenotypes in mouse models of Huntington's disease. Brain Res Bull 88:81\u201393","journal-title":"Brain Res Bull"},{"key":"8556_CR57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1750-1326-6-81","volume":"6","author":"X Chen","year":"2011","unstructured":"Chen X, Wu J, Lvovskaya S, Herndon E, Supnet C, Bezprozvanny I (2011) Dantrolene is neuroprotective in Huntington's disease transgenic mouse model. Mol Neurodegener 6:81","journal-title":"Mol Neurodegener"},{"key":"8556_CR58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","volume":"101","author":"A Yamamoto","year":"2000","unstructured":"Yamamoto A, Lucas JJ, Hen R (2000) Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 101:57\u201366","journal-title":"Cell"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-013-8556-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-013-8556-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-013-8556-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T22:17:38Z","timestamp":1564611458000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-013-8556-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,7]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["8556"],"URL":"https:\/\/doi.org\/10.1007\/s12035-013-8556-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,7]]}}}